KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Gains from Investment Securities (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Gains from Investment Securities for 15 consecutive years, with -$6.1 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 192.17% to -$6.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.8 million through Dec 2025, up 4.97% year-over-year, with the annual reading at -$1.9 million for FY2025, 9.07% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$6.1 million at Supernus Pharmaceuticals, down from $274000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $16.2 million in Q4 2022, with the low at -$28.6 million in Q4 2023.
  • Average Gains from Investment Securities over 5 years is -$1.8 million, with a median of -$2000.0 recorded in 2021.
  • The sharpest move saw Gains from Investment Securities surged 12746.03% in 2022, then tumbled 2827.38% in 2023.
  • Over 5 years, Gains from Investment Securities stood at $126000.0 in 2021, then skyrocketed by 12746.03% to $16.2 million in 2022, then tumbled by 276.52% to -$28.6 million in 2023, then surged by 92.71% to -$2.1 million in 2024, then crashed by 192.17% to -$6.1 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$6.1 million, $274000.0, and -$2.1 million for Q4 2025, Q1 2025, and Q4 2024 respectively.